{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:25:44Z","timestamp":1792513544051,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.imbio.2021.152085","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T03:44:31Z","timestamp":1616816671000},"page":"152085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Development of dominant epitope-based vaccines encoding Gp63, Kmp-11 and Amastin against visceral leishmaniasis"],"prefix":"10.1016","volume":"226","author":[{"given":"Jianhui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuechun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxiao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dali","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2021.152085_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00268","article-title":"Experimental validation of multi-epitope peptides including promising MHC class I- and II-restricted epitopes of four known Leishmania infantum proteins","volume":"5","author":"Agallou","year":"2014","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.imbio.2021.152085_b0010","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.4049\/jimmunol.174.11.7160","volume":"174","author":"Basu","year":"2005","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.imbio.2021.152085_b0015","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1586\/14760584.6.6.939","article-title":"Epitope-based vaccine against influenza","volume":"6","author":"Ben-Yedidia","year":"2007","journal-title":"Expert. Re.v Vaccines"},{"issue":"8","key":"10.1016\/j.imbio.2021.152085_b0020","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/eji.200839017","article-title":"Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10","volume":"39","author":"Bhaumik","year":"2009","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2021.152085_b0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.exppara.2011.01.012","article-title":"Leishmania major: Protective capacity of DNA vaccine using amastin fused to HSV-1 VP22 and EGFP in BALB\/c mice model","volume":"128","author":"Bolhassani","year":"2011","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.imbio.2021.152085_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01043","article-title":"Peptide vaccines for leishmaniasis","volume":"9","author":"De Brito","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2021.152085_b0035","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3389\/fimmu.2015.00524","article-title":"Kinetoplastid membrane protein-11 as a vaccine candidate and a virulence factor in Leishmania","volume":"6","author":"de Mendon\u00e7a","year":"2015","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2021.152085_b0040","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-015-1246-y","article-title":"HisAK70: progress towards a vaccine against different forms of leishmaniosis","volume":"8","author":"Dom\u00ednguez-Bernal","year":"2015","journal-title":"Parasit. Vectors"},{"issue":"6","key":"10.1016\/j.imbio.2021.152085_b0045","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0002-9440(10)63262-2","article-title":"Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection","volume":"165","author":"Engwerda","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.imbio.2021.152085_b0050","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0167-5699(99)01549-2","article-title":"Organ-specific immune responses associated with infectious disease","volume":"21","author":"Engwerda","year":"2000","journal-title":"Immunol. Today"},{"issue":"7","key":"10.1016\/j.imbio.2021.152085_b0055","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/trstmh\/trv039","article-title":"Development of Leishmania vaccines in the era of visceral leishmaniasis elimination","volume":"109","author":"Engwerda","year":"2015","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"7","key":"10.1016\/j.imbio.2021.152085_b0060","doi-asserted-by":"crossref","first-page":"e2914","DOI":"10.1371\/journal.pntd.0002914","article-title":"Immune regulation during chronic visceral leishmaniasis","volume":"8","author":"Faleiro","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"46","key":"10.1016\/j.imbio.2021.152085_b0065","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1016\/j.vaccine.2008.05.095","article-title":"Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein","volume":"26","author":"Fernandes","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.imbio.2021.152085_b0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-94-007-7305-9_3","article-title":"A2 and other visceralizing proteins of Leishmania: role in pathogenesis and application for vaccine development","volume":"74","author":"Fernandes","year":"2014","journal-title":"Subcell Biochem."},{"key":"10.1016\/j.imbio.2021.152085_b0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006406","article-title":"Vaccination with leishmania hemoglobin receptor-encoding DNA protects against visceral leishmaniasis","volume":"5","author":"Guha","year":"2013","journal-title":"Sci Transl Med."},{"issue":"4","key":"10.1016\/j.imbio.2021.152085_b0080","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0952-7915(00)00118-7","article-title":"DNA vaccines: a key for inducing long-term cellular immunity","volume":"12","author":"Gurunathan","year":"2000","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2021.152085_b0085","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s12026-015-8746-x","article-title":"Construction of recombinant Mip-FlaA dominant epitope vaccine against Legionella pneumophila and evaluation of the immunogenicity and protective immunity","volume":"64","author":"He","year":"2016","journal-title":"Immunol. Res."},{"issue":"1","key":"10.1016\/j.imbio.2021.152085_b0090","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/imm.13007","article-title":"DNA prime-protein boost vaccine encoding HLA-A2, HLA-A24 and HLA-DR1 restricted epitopes of CaNA2 against visceral leishmaniasis","volume":"156","author":"He","year":"2019","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.imbio.2021.152085_b0095","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/14760584.2018.1459191","article-title":"Vaccine candidates against leishmania under current research","volume":"17","author":"Iborra","year":"2018","journal-title":"Expert. Rev. Vaccines"},{"issue":"10","key":"10.1016\/j.imbio.2021.152085_b0100","doi-asserted-by":"crossref","first-page":"e0005011","DOI":"10.1371\/journal.pntd.0005011","article-title":"Immunotherapeutic potential of eugenol emulsion in experimental visceral leishmaniasis","volume":"10","author":"Islamuddin","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.imbio.2021.152085_b0105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fcimb.2012.00072","article-title":"Impact of Leishmania metalloprotease GP63 on macrophage signaling","volume":"2","author":"Isnard","year":"2012","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"32","key":"10.1016\/j.imbio.2021.152085_b0110","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1016\/j.vaccine.2007.05.009","article-title":"The role of CpG ODN in enhancement of immune response and protection in BALB\/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome","volume":"25","author":"Jaafari","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.imbio.2021.152085_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2015.03.017","article-title":"Vaccines for visceral leishmaniasis: A review","volume":"422","author":"Jain","year":"2015","journal-title":"J. Immunol. Methods."},{"issue":"1","key":"10.1016\/j.imbio.2021.152085_b0120","first-page":"181","article-title":"The antigenic index: a novel algorithm for predicting antigenic determinants","volume":"4","author":"Jameson","year":"1988","journal-title":"Comput. Appl. Biosci."},{"issue":"11","key":"10.1016\/j.imbio.2021.152085_b0125","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri3307","article-title":"Transcriptional control of effector and memory CD8+ T cell differentiation","volume":"12","author":"Kaech","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.imbio.2021.152085_b0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00281-015-0548-7","article-title":"Lessons from other diseases: granulomatous inflammation in leishmaniasis","volume":"38","author":"Kaye","year":"2016","journal-title":"Semin. Immunopathol."},{"issue":"1","key":"10.1016\/j.imbio.2021.152085_b0135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.0105-2896.2004.00188.x","article-title":"The immunopathology of experimental visceral leishmaniasis","volume":"201","author":"Kaye","year":"2004","journal-title":"Immunol. Rev."},{"issue":"8","key":"10.1016\/j.imbio.2021.152085_b0140","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1128\/IAI.72.8.4924-4928.2004","article-title":"DNA-Salmonella enterica serovar Typhimurium primer-booster vaccination biases towards T helper 1 responses and enhances protection against Leishmania major infection in mice","volume":"72","author":"Lange","year":"2004","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.imbio.2021.152085_b0145","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1084\/jem.157.5.1562","article-title":"Surface antigens of Leishmania donovani promastigotes","volume":"157","author":"Lepay","year":"1983","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2021.152085_b0150","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13071-016-1413-9","article-title":"Study of Leishmania pathogenesis in mice: experimental considerations","volume":"9","author":"Loeuillet","year":"2016","journal-title":"Parasit. Vectors"},{"issue":"3","key":"10.1016\/j.imbio.2021.152085_b0155","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.coi.2009.05.016","article-title":"Heterologous prime-boost vaccination","volume":"21","author":"Lu","year":"2009","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2021.152085_b0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1297-9716-45-69","article-title":"The protective immune response produced in dogs after primary vaccination with the LiESP\/QA-21 vaccine (CaniLeish\u00ae) remains effective against an experimental challenge one year later","volume":"45","author":"Martin","year":"2014","journal-title":"Vet. Res."},{"issue":"3","key":"10.1016\/j.imbio.2021.152085_b0165","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/apm.12651","article-title":"Immunogenicity and efficacy of a bivalent DNA vaccine containing LeIF and TSA genes against murine cutaneous leishmaniasis","volume":"125","author":"Maspi","year":"2017","journal-title":"APMIS"},{"issue":"2","key":"10.1016\/j.imbio.2021.152085_b0170","doi-asserted-by":"crossref","first-page":"e14644","DOI":"10.1371\/journal.pone.0014644","article-title":"Potency, efficacy and durability of DNA\/DNA, DNA\/protein and protein\/protein based vaccination using gp63 against Leishmania donovani in BALB\/c mice","volume":"6","author":"Mazumder","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.imbio.2021.152085_b0175","doi-asserted-by":"crossref","unstructured":"Mou, Z., Li, J., Boussoffara, T., et al., 2015. Identification of broadly conserved cross-species protective Leishmania antigen and its responding CD4+ T cells. Sci Transl Med. 7(310):310ra167.","DOI":"10.1126\/scitranslmed.aac5477"},{"issue":"1","key":"10.1016\/j.imbio.2021.152085_b0180","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-immunol-032712-095954","article-title":"Memory T cell subsets, migration patterns, and tissue residence","volume":"31","author":"Mueller","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.imbio.2021.152085_b0185","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1128\/CVI.00188-06","article-title":"Amastin peptide-binding antibodies as biomarkers of active human visceral leishmaniasis","volume":"13","author":"Rafati","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"issue":"3-4","key":"10.1016\/j.imbio.2021.152085_b0190","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0264-410X(01)00341-3","article-title":"Attenuated Toxoplasma gondii ts-4 mutants engineered to express the Leishmania antigen KMP-11 elicit a specific immune response in BALB\/c mice","volume":"20","author":"Ram\u0131\u0301rez","year":"2001","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.imbio.2021.152085_b0195","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.molbiopara.2005.01.006","article-title":"Characterization and developmental gene regulation of a large gene family encoding amastin surface proteins in Leishmania spp.","volume":"140","author":"Rochette","year":"2005","journal-title":"Mol. Biochem. Parasitol."},{"issue":"1","key":"10.1016\/j.imbio.2021.152085_b0200","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-016-1412-x","article-title":"Regulation of immunity during visceral Leishmania infection","volume":"9","author":"Rodrigues","year":"2016","journal-title":"Parasit. Vectors"},{"issue":"12","key":"10.1016\/j.imbio.2021.152085_b0205","first-page":"1493","article-title":"Immunization against Leishmania major infection in BALB\/c mice using a subunit-based DNA vaccine derived from TSA, LmSTI1, KMP11, and LACK predominant antigens","volume":"22","author":"Salehi-Sangani","year":"2019","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"2","key":"10.1016\/j.imbio.2021.152085_b0210","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/sj.icb7100011","article-title":"Balancing immunity and pathology in visceral leishmaniasis","volume":"85","author":"Stanley","year":"2007","journal-title":"Immunol. Cell Biol."},{"issue":"1","key":"10.1016\/j.imbio.2021.152085_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0166-6851(95)00022-S","article-title":"Kinetoplastid membrane protein-11 (KMP-11) is differentially expressed during the life cycle of African trypanosomes and is found in a wide variety of kinetoplastid parasites","volume":"71","author":"Stebeck","year":"1995","journal-title":"Mol. Biochem. Parasitol."},{"issue":"14","key":"10.1016\/j.imbio.2021.152085_b0220","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.vaccine.2005.12.012","article-title":"From genome to vaccines for leishmaniasis: screening 100 novel vaccine candidates against murine Leishmania major infection","volume":"24","author":"Stober","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.imbio.2021.152085_b0225","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/infdis\/jiy552","article-title":"The potent ITK\/BTK inhibitor ibrutinib is effective for the treatment of experimental visceral leishmaniasis caused by Leishmania donovani","volume":"219","author":"Varikuti","year":"2019","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.imbio.2021.152085_b0230","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/tmi.13382","article-title":"Commercially approved vaccines for canine leishmaniosis: a review of available data on their safety and efficacy","volume":"25","author":"Velez","year":"2020","journal-title":"Trop. Med. Int. Health."},{"key":"10.1016\/j.imbio.2021.152085_b0235","unstructured":"World Health Organization. Leishmaniasis. 2019. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis. Accessed 19 August 2020."},{"issue":"1","key":"10.1016\/j.imbio.2021.152085_b0240","first-page":"1","article-title":"Protection against Leishmania major infection in genetically susceptible BALB\/c mice by gp63 delivered orally in attenuated Salmonella typhimurium (AroA- AroD-)","volume":"85","author":"Xu","year":"1995","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.imbio.2021.152085_b0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230381","article-title":"The immunogenicity and protective immunity of multi-epitopes DNA prime-protein boost vaccines encoding Amastin-Kmp-11, Kmp11-Gp63 and Amastin-Gp63 against visceral leishmaniasis","volume":"15","author":"Zhang","year":"2020","journal-title":"PLoS One"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298521000334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298521000334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:48:14Z","timestamp":1759250894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298521000334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0171298521000334"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2021.152085","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of dominant epitope-based vaccines encoding Gp63, Kmp-11 and Amastin against visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2021.152085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152085"}}